021-51111890
购物车（）
sales@molnova.cn
ICCB280
CAS No. 2041072-41-5
ICCB280 ( —— )
产品货号. M23912 CAS No. 2041072-41-5
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥875 | 有现货 |
|
| 5MG | ￥1442 | 有现货 |
|
| 10MG | ￥2608 | 有现货 |
|
| 25MG | ￥4228 | 有现货 |
|
| 50MG | ￥6148 | 有现货 |
|
| 100MG | ￥8586 | 有现货 |
|
| 500MG | ￥17253 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称ICCB280
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
-
产品描述ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体C/EBPα
-
研究领域——
-
适应症——
化学信息
-
CAS Number2041072-41-5
-
分子量386.4
-
分子式C23H18N2O4
-
纯度>98% (HPLC)
-
溶解度DMSO:85mg/mL (219.98mM)
-
SMILESO=C1N(C2=CC=CC=C2OC)C(/C=C/C3=CC=C(O)C(O)=C3)=NC4=C1C=CC=C4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Radomska HS, Jernigan F, Nakayama S, et al. A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation. J Biomol Screen. 2015;20(9):1150-1159. doi:10.1177/1087057115592220
产品手册
关联产品
-
(3beta,22alpha)-26-(...
Anemarsaponin E analogue. Reference standards.
-
Methyl cyclohexaneca...
Methyl cyclohexanecarboxylate is an endogenous metabolite and used as a material for chemical synthesis.
-
Azeliragon
An orally bioavailable small molecule inhibitor of RAGE.
